GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mangalam Drugs & Organics Ltd (BOM:532637) » Definitions » E10

Mangalam Drugs & Organics (BOM:532637) E10 : ₹10.27 (As of Dec. 2023)


View and export this data going back to 2005. Start your Free Trial

What is Mangalam Drugs & Organics E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Mangalam Drugs & Organics's adjusted earnings per share data for the three months ended in Dec. 2023 was ₹0.310. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ₹10.27 for the trailing ten years ended in Dec. 2023.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2024-05-31), Mangalam Drugs & Organics's current stock price is ₹101.65. Mangalam Drugs & Organics's E10 for the quarter that ended in Dec. 2023 was ₹10.27. Mangalam Drugs & Organics's Shiller PE Ratio of today is 9.90.

During the past 13 years, the highest Shiller PE Ratio of Mangalam Drugs & Organics was 31.84. The lowest was 9.02. And the median was 17.84.


Mangalam Drugs & Organics E10 Historical Data

The historical data trend for Mangalam Drugs & Organics's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mangalam Drugs & Organics E10 Chart

Mangalam Drugs & Organics Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 5.71 6.91 - -

Mangalam Drugs & Organics Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 10.15 10.13 10.27 -

Competitive Comparison of Mangalam Drugs & Organics's E10

For the Drug Manufacturers - Specialty & Generic subindustry, Mangalam Drugs & Organics's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mangalam Drugs & Organics's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Mangalam Drugs & Organics's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Mangalam Drugs & Organics's Shiller PE Ratio falls into.



Mangalam Drugs & Organics E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Mangalam Drugs & Organics's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=0.31/152.9243*152.9243
=0.310

Current CPI (Dec. 2023) = 152.9243.

Mangalam Drugs & Organics Quarterly Data

per share eps CPI Adj_EPS
201403 2.950 91.425 4.934
201406 -0.150 94.103 -0.244
201409 1.520 96.780 2.402
201412 0.640 96.780 1.011
201503 2.650 97.163 4.171
201506 2.320 99.841 3.554
201509 3.220 101.753 4.839
201512 2.400 102.901 3.567
201603 3.500 102.518 5.221
201606 2.880 105.961 4.156
201609 3.250 105.961 4.690
201612 3.850 105.196 5.597
201703 4.110 105.196 5.975
201706 2.630 107.109 3.755
201709 4.230 109.021 5.933
201712 3.780 109.404 5.284
201803 1.930 109.786 2.688
201806 0.420 111.317 0.577
201809 1.090 115.142 1.448
201812 -2.790 115.142 -3.706
201903 -3.790 118.202 -4.903
201906 0.470 120.880 0.595
201909 0.510 123.175 0.633
201912 1.040 126.235 1.260
202003 3.190 124.705 3.912
202006 5.240 127.000 6.310
202009 7.000 130.118 8.227
202012 4.070 130.889 4.755
202103 1.360 131.771 1.578
202106 2.790 134.084 3.182
202109 2.860 135.847 3.220
202112 2.540 138.161 2.811
202203 4.230 138.822 4.660
202206 1.900 142.347 2.041
202209 1.410 144.661 1.491
202212 0.000 145.763 0.000
202303 0.000 146.865 0.000
202306 -6.020 150.280 -6.126
202309 -2.260 151.492 -2.281
202312 0.310 152.924 0.310

Add all the adjusted EPS together and divide 10 will get our e10.


Mangalam Drugs & Organics  (BOM:532637) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Mangalam Drugs & Organics's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=101.65/10.27
=9.90

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Mangalam Drugs & Organics was 31.84. The lowest was 9.02. And the median was 17.84.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Mangalam Drugs & Organics E10 Related Terms

Thank you for viewing the detailed overview of Mangalam Drugs & Organics's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Mangalam Drugs & Organics (BOM:532637) Business Description

Traded in Other Exchanges
Address
239, P. D’Mello Road, Rupam Building, 3rd Floor, Near General Post Office, Mumbai, MH, IND, 400001
Mangalam Drugs & Organics Ltd is an Indian company operating in the healthcare sector. It is engaged in the research and development and manufacturing of drugs. Its product range includes Active Pharmaceutical Ingredients (APIs), Intermediates, and Specialty chemicals. Its sales comprise of sales in the Indian and overseas markets.

Mangalam Drugs & Organics (BOM:532637) Headlines

No Headlines